Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Federal funding opportunity PAR-25-095 from National Institutes of Health (Department of Health and Human Services).
Apply on Grants.gov →Application closes November 6, 2026
- Posted
- November 18, 2024
- Closes
- November 6, 2026
- Award ceiling
- $350,000
- Program funding
- $350,000
- Cost sharing
- No
- Instrument
- Grant
- Assistance listing
- 93.172, 93.393, 93.866, 93.121
- Archives
- December 6, 2026
Program funding history
Awards made under Assistance Listing 93.172 across FY2024–FY2026, from public federal spending records.
- FY2024 obligated
- $441.6M
- FY2025 obligated
- $420.8M
- FY2026 (to date) obligated
- $179.2M
- Awards in window
- 1,263
Top recipients: University of Washington, The Leland Stanford Junior University, The Broad Institute, Inc, The Johns Hopkins University, University of North Carolina at Chapel Hill
Source: USAspending.gov · refreshed July 2026
Synopsis
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.
Who can apply
- City or township governments
- State governments
- Independent school districts
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Public housing authorities/Indian housing authorities
- Special district governments
- For profit organizations other than small businesses
- Public and State controlled institutions of higher education
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Small businesses
- Native American tribal organizations (other than Federally recognized tribal governments)
- County governments
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Native American tribal governments (Federally recognized)
- Private institutions of higher education
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
How to apply
Applications go through the official government listing. Grants Radar links you straight to the source.
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon. Unsubscribe in one click.
Similar grants
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)
- Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
Never miss a funding deadline again
Grants Radar sends AI-enriched alerts on federal grants and contracts matched to what you do. Founding seats are limited and locked for life.
Get funding alerts